Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C
- 17 July 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (2) , 197-203
- https://doi.org/10.1016/0006-2952(95)00126-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Tolfenamic Acid and Leukotriene Synthesis InhibitionBasic & Clinical Pharmacology & Toxicology, 1994
- Are There Differences Among Nonsteroidal Antiinflammatory Drugs?Arthritis & Rheumatism, 1994
- Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functionsInflammation, 1993
- Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugsCurrent Opinion in Rheumatology, 1992
- SK&F 96365, a novel inhibitor of receptor-mediated calcium entryBiochemical Journal, 1990
- The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burstBiochemical and Biophysical Research Communications, 1990
- Potent selective inhibitors of protein kinase CFEBS Letters, 1989
- Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytesin vitroInflammation Research, 1988
- Meclofenamate sodium monohydrate inhibits chemotactic factor–induced human polymorphonuclear leukocyte function. a possible explanation for its antiinflammatory effectArthritis & Rheumatism, 1987
- Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitroProstaglandins, Leukotrienes and Medicine, 1986